Caren Deardorf

Chief Commercial Officer

As Chief Commercial Officer, Caren serves as a member of Magenta’s Executive Team and is responsible for the strategy, direction and execution of Magenta’s global commercial capabilities.

Caren has more than 25 years of international biotechnology leadership experience across a range of therapeutic areas. She came to Magenta from Ohana Biosciences, where she served as the Chief Commercial Officer, developing commercial strategy for fundraising and business development efforts, including planning for the company’s first commercial product launch. Prior to that, she held a variety of commercial roles of increasing responsibility at Biogen, leading and building successful global brands. Most recently, she served as the Vice President, Global Product Development & Commercialization Lead, SPINRAZA® and SMA Portfolio, where she executed the global launch of the first therapy for spinal muscular atrophy (SMA).

She holds an MBA from Babson College and a Bachelor of Science degree in Biology from Tufts University.